￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Selinisol/ruxolitinib combination is tolerated and exhibits durable splenic symptomatic response in JAK inhibitor–primary myelofibrosis

2026-02-01 22:25:32

Check Details
Dose adjustment of selinesol improves survival, response rate and QOL in MM

2026-02-01 22:25:32

Check Details
Seleniso drug prices in 2024

2026-02-01 22:25:32

Check Details
Good news not to be missed! Seleniso will be included in medical insurance in 2024

2026-02-01 22:25:32

Check Details
What kind of targeted drug is Selinisol? What will happen if you eat it?

2026-02-01 22:25:32

Check Details
What are the functions and effects of selinesol tablets?

2026-02-01 22:25:32

Check Details
Must-read for patients: Overview of basic information on Seleniso’s Chinese instructions

2026-02-01 22:25:32

Check Details
Comparison of domestic and foreign market pricing of Seleniso drugs

2026-02-01 22:25:32

Check Details
Seleniso was successfully included in the national medical insurance directory to assist the treatment of multiple myeloma

2026-02-01 22:25:32

Check Details
Selinisol: a novel nuclear export inhibitor for personalized treatment of multiple myeloma

2026-02-01 22:25:32

Check Details
Selinisol tablets: Demonstrated efficacy against multiple myeloma and various cancers

2026-02-01 22:25:32

Check Details
Seleniso User Guide

2026-02-01 22:25:32

Check Details
Category
相关知识